Teads N.V. TEAD 深 沪
等待开盘 08-28 09:30:00 美东时间
1.79
+0.030
+1.70%
华盛通- 最 高1.82
- 今 开1.77
- 成交量 28.50万股
- 最 低 1.74
- 昨 收 1.76
- 总市值 1.69亿
- 52周最高 7.87
- 市盈率 静 --
- 换手率 0.30%
- 52周最低 1.655
- 委 比 -37.42%
- 总股本 9430.01万
- 历史最高 20.99
- 量 比 0.82
- 振 幅 4.55%
- 历史最低 1.655
- 每 手 1
- 风险率 1.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Teads Holding Co. to Participate in Upcoming Investor Conferences
Teads Holding Co. (NASDAQ: TEAD) announced that its senior management will participate in two investor conferences in September 2025: Citi’s Global TMT Conference in New York on September 3 and Jefferies TechTrek Conference in Tel Aviv on September 10-11. Management will also hold one-on-one meetings with investors. Teads, formed by the merger of Teads and Outbrain Inc., operates as an omnichannel outcomes platform for the Open Internet, utilizin...
08-21 20:05
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Needham Maintains Buy on Teads Holding, Lowers Price Target to $3.5
Needham analyst Laura Martin maintains Teads Holding (NASDAQ:TEAD) with a Buy and lowers the price target from $5 to $3.5.
08-08 01:12
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Teads Unveils Connected Ads: A New Premium Brand and Performance Solution for the Open Internet
Teads has launched beta testing for Connected Ads, an innovative advertising format with two complementary placements within a single publisher page. The first placement appears within the article, while the second one loads as users scroll, offering brands additional high-impact opportunities to engage and maximize attention. This exclusive solution emphasizes storytelling, creativity, and brand-to-performance outcomes, reflecting Teads' commitm...
07-31 12:03
Teads to Release Second Quarter 2025 Financial Results on August 7, 2025
Teads Holding Co. will release its Q2 2025 results before the market opens on August 7, 2025, followed by a conference call at 8:30 a.m. ET. The call can be accessed via phone (1-888-437-3179 or 1-862-298-0702) with passcode 13754497. A replay will be available two hours post-call until August 21. Investors can also listen to a webcast on Teads' Investor Relations website.
07-24 20:04
上海、湖南国资参投！前上市公司研究员离职创业 收获一个创新药IPO
①麦济生物提交港股上市招股书，计划融资用于MG-K10相关产品的研发和临床试验，并推动该药剂在哮喘、慢性阻塞性肺病等疾病的临床试验。 ②公司2023年至2025年Q1的研发相关费用分别为1.66亿元、1.5亿元及0.24亿元，净亏损有所收窄。
07-16 07:04
Outbrain Completes Name Change to Teads Holding Co., To Begin Trading Under New Nasdaq Symbol 'TEAD' Effective June 10
Outbrain Inc. (NASDAQ:OB), which is operating under the new Teads brand following Outbrain's acquisition of Teads in February 2025, announced today that the combined company has completed its corporate renaming from
06-09 19:19
Outbrain Completes Change of Corporate Name to Teads
Outbrain Inc., operating under the new Teads brand after acquiring Teads in February 2025, has renamed the combined company to "Teads Holding Co." and will begin trading on the Nasdaq under the ticker "TEAD" from June 10, 2025. CEO David Kostman highlighted the rebrand as a milestone, positioning Teads as a leading omnichannel outcomes platform for measurable advertiser results on the premium open internet. The name change does not affect stockho...
06-09 11:00
